"10.1371_journal.pone.0108982","plos one","2014-10-17T00:00:00Z","Carles Gaig; Dolores Vilas; Jon Infante; María Sierra; Inés García-Gorostiaga; Mariateresa Buongiorno; Mario Ezquerra; Maria José Martí; Francesc Valldeoriola; Miquel Aguilar; Matilde Calopa; Jorge Hernandez-Vara; Eduardo Tolosa","Parkinson’s Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociències Hospital Clínic, University of Barcelona, Barcelona, Spain; Institut d’investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain; Neurology Service, Hospital Universitario Marqués de Valdecilla, University of Cantabria (UC), Santander, Spain; Neurology Service, Hospital de Galdakao, Usansolo, Vizcaya, Spain; Neurology Service, Hospital Universitari Mutua de Terrasa, Barcelona, Spain; Neurology Service, Hospital Universitari de Bellvitge, Barcelona, Spain; Neurology Service, Hospital Universitari Vall D’Hebron, Barcelona, Spain","Conceived and designed the experiments: CG DV ET. Performed the experiments: CG DV JI MS IG MA MC JH. Analyzed the data: CG DV JI MS IG ME MB MM FV ET. Contributed reagents/materials/analysis tools: CG DV JI MS IG ME MB MM FV ET. Contributed to the writing of the manuscript: CG DV ET.","Dr. Tolosa received honoraria for consultancy from Novartis, TEVA, Boehringer Ingelheim, UCB, Solvay, Lundbeck, and TEVA, and he received funding for research from Spaniard Network for Research on neurodegenerative Disorders (CIBERNED)- instituto Carlos III (ISCIII), The Michael J. Fox Foundation for Parkinson’s Research (MJFF), and Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS). Dr. Infante receives research support from the Fondo de Investigación Sanitaria-ISCIII (PI11/00228) and from “Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas” (CIBERNED) (CB06/05/0037). Dr. Sierra receives research support from the Institute for Formation and Research from the Marqués de Valdecilla Foundation-IFIMAV (WLA 04/11) and from “Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas” (CIBERNED) (CB06/05/0037). Dr. Ezquerra was supported by a Miguel Servet contract of the Instituto de Salud Carlos III (ISCIII). Dr. Valldeoriola has received honoraria from Medtronic Ibérica, Boston Scientific, Abbvie Pharmaceutiocals and UCB pharma for lectures and courses. Dr. Gaig, Dr. Vilas, Dr. Buongiorno, Dr. Martí, Dr. García- Gorostiaga, Dr. Aguilar, Dr. Calopa, and Dr. Hernandez-Vara report no disclosures. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","10","Carles Gaig","CG",13,TRUE,3,8,10,NA,TRUE,TRUE,FALSE,0,NA,FALSE
